Baird Financial Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154K | Buy |
|
|||||
|
2025
Q1 | $105K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $285K | Buy |
|
|||||
|
2022
Q1 | $384K | Buy |
|
|||||
|
2021
Q4 | $395K | Sell |
|
|||||
|
2021
Q3 | $463K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $554K | Sell |
|
|||||
|
2016
Q2 | $1.7M | Sell |
|
|||||
|
2016
Q1 | $3.33M | Buy |
|
|||||
|
2015
Q4 | $3.78M | Sell |
|
|||||
|
2015
Q3 | $3.28M | Sell |
|
|||||
|
2015
Q2 | $3.07M | Buy |
|